These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1261 related articles for article (PubMed ID: 12669968)

  • 21. Protein encapsulation and release from poly(lactide-co-glycolide) microspheres: effect of the protein and polymer properties and of the co-encapsulation of surfactants.
    Blanco D; Alonso MJ
    Eur J Pharm Biopharm; 1998 May; 45(3):285-94. PubMed ID: 9653633
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Enhanced encapsulation and bioavailability of breviscapine in PLGA microparticles by nanocrystal and water-soluble polymer template techniques.
    Wang H; Zhang G; Ma X; Liu Y; Feng J; Park K; Wang W
    Eur J Pharm Biopharm; 2017 Jun; 115():177-185. PubMed ID: 28263795
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Liraglutide-loaded poly(lactic-co-glycolic acid) microspheres: Preparation and in vivo evaluation.
    Wu J; Williams GR; Branford-White C; Li H; Li Y; Zhu LM
    Eur J Pharm Sci; 2016 Sep; 92():28-38. PubMed ID: 27343696
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Insulin-loaded biodegradable PLGA microcapsules: initial burst release controlled by hydrophilic additives.
    Yamaguchi Y; Takenaga M; Kitagawa A; Ogawa Y; Mizushima Y; Igarashi R
    J Control Release; 2002 Jun; 81(3):235-49. PubMed ID: 12044564
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Insulin-loaded PLGA/cyclodextrin large porous particles with improved aerosolization properties: in vivo deposition and hypoglycaemic activity after delivery to rat lungs.
    Ungaro F; d'Emmanuele di Villa Bianca R; Giovino C; Miro A; Sorrentino R; Quaglia F; La Rotonda MI
    J Control Release; 2009 Apr; 135(1):25-34. PubMed ID: 19154761
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sodium fusidate-poly(D,L-lactide-co-glycolide) microspheres: preparation, characterisation and in vivo evaluation of their effectiveness in the treatment of chronic osteomyelitis.
    Cevher E; Orhan Z; Sensoy D; Ahiskali R; Kan PL; Sağirli O; Mülazimoğlu L
    J Microencapsul; 2007 Sep; 24(6):577-95. PubMed ID: 17654177
    [TBL] [Abstract][Full Text] [Related]  

  • 27. PLGA microspheres for oral osteopenia treatment: preliminary "in vitro"/"in vivo" evaluation.
    Perugini P; Genta I; Conti B; Modena T; Cocchi D; Zaffe D; Pavanetto F
    Int J Pharm; 2003 Apr; 256(1-2):153-60. PubMed ID: 12695021
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Multi-arm histidine copolymer for controlled release of insulin from poly(lactide-co-glycolide) microsphere.
    Park W; Kim D; Kang HC; Bae YH; Na K
    Biomaterials; 2012 Dec; 33(34):8848-57. PubMed ID: 22959184
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Porcine insulin biodegradable polyester microspheres: stability and in vitro release characteristics.
    Shao PG; Bailey LC
    Pharm Dev Technol; 2000; 5(1):1-9. PubMed ID: 10669912
    [TBL] [Abstract][Full Text] [Related]  

  • 30. HP55-coated capsule containing PLGA/RS nanoparticles for oral delivery of insulin.
    Wu ZM; Zhou L; Guo XD; Jiang W; Ling L; Qian Y; Luo KQ; Zhang LJ
    Int J Pharm; 2012 Apr; 425(1-2):1-8. PubMed ID: 22248666
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of osmotic pressure in the solvent extraction phase on BSA release profile from PLGA microspheres.
    Jiang G; Thanoo BC; DeLuca PP
    Pharm Dev Technol; 2002 Nov; 7(4):391-9. PubMed ID: 12503521
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect of cyclodextrins on the in vitro and in vivo properties of insulin-loaded poly (D,L-lactic-co-glycolic acid) microspheres.
    Rodrigues Júnior JM; de Melo Lima K; de Matos Jensen CE; de Aguiar MM; da Silva Cunha Júnior A
    Artif Organs; 2003 May; 27(5):492-7. PubMed ID: 12752215
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Biodegradable PLGA microspheres loaded with ganciclovir for intraocular administration. Encapsulation technique, in vitro release profiles, and sterilization process.
    Herrero-Vanrell R; Ramirez L; Fernandez-Carballido A; Refojo MF
    Pharm Res; 2000 Oct; 17(10):1323-8. PubMed ID: 11145241
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmaceutical and immunological evaluation of a single-shot hepatitis B vaccine formulated with PLGA microspheres.
    Shi L; Caulfield MJ; Chern RT; Wilson RA; Sanyal G; Volkin DB
    J Pharm Sci; 2002 Apr; 91(4):1019-35. PubMed ID: 11948541
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of formulation parameters on encapsulation efficiency and release behavior of risperidone poly(D,L-lactide-co-glycolide) microsphere.
    Su Z; Sun F; Shi Y; Jiang C; Meng Q; Teng L; Li Y
    Chem Pharm Bull (Tokyo); 2009 Nov; 57(11):1251-6. PubMed ID: 19881277
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bioadhesive fluorescent microspheres as visible carriers for local delivery of drugs. I: preparation and characterization of insulin-loaded PCEFB/PLGA microspheres.
    Jiang HL; Zhu KJ
    J Microencapsul; 2002; 19(4):451-61. PubMed ID: 12396382
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Subconjunctivally administered celecoxib-PLGA microparticles sustain retinal drug levels and alleviate diabetes-induced oxidative stress in a rat model.
    Ayalasomayajula SP; Kompella UB
    Eur J Pharmacol; 2005 Mar; 511(2-3):191-8. PubMed ID: 15792788
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Preparation, characterization, and in vitro evaluation of physostigmine-loaded poly(ortho ester) and poly(ortho ester)/poly(D,L-lactide-co-glycolide) blend microspheres fabricated by spray drying.
    Wang L; Chaw CS; Yang YY; Moochhala SM; Zhao B; Ng S; Heller J
    Biomaterials; 2004 Jul; 25(16):3275-82. PubMed ID: 14980422
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Modulated release of IdUrd from poly (D,L-lactide-co-glycolide) microspheres by addition of poly (D,L-lactide) oligomers.
    Geze A; Venier-Julienne MC; Saulnier P; Varlet P; Daumas-Duport C; Devauchelle P; Benoit JP
    J Control Release; 1999 Apr; 58(3):311-22. PubMed ID: 10099156
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterization of poly(glycolide-co-D,L-lactide)/poly(D,L-lactide) microspheres for controlled release of GM-CSF.
    Pettit DK; Lawter JR; Huang WJ; Pankey SC; Nightlinger NS; Lynch DH; Schuh JA; Morrissey PJ; Gombotz WR
    Pharm Res; 1997 Oct; 14(10):1422-30. PubMed ID: 9358556
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 64.